Wallife is a technology company.
Wallife has raised $12.0M across 1 funding round.
Wallife has raised $12.0M in total across 1 funding round.
Wallife is an Italian insurtech startup founded in 2020 that specializes in protecting individuals and businesses from emerging risks at the intersection of technology, science, and safety, particularly in biometrics, genetics, and biohacking.[1][2][3][4][5] The company develops innovative insurance products, such as Biometrics ID, which secures digital identities against threats like malware, phishing, and device hacking through proprietary threat-scanning technology and reimbursement for theft.[3] Wallife serves individuals and enterprises facing novel dangers from tech advancements, addressing gaps in traditional insurance by identifying unknown risks to biological and digital identities; it has raised $21.85M total funding, employs around 30 people blending insurance and tech expertise, and recently partnered on cryopreservation insurance.[1][3][4]
Wallife was founded in 2020 (with some sources noting 2021 for formal setup) in Rome, Italy, by Fabio Sbianchi, a visionary entrepreneur who previously founded Octo Telematics in 2002, and Maria Enrica Angelone, the current CEO.[2][3][5] The idea emerged from recognizing unprotected risks from rapid technological and scientific progress in genetics (e.g., biological material preservation), biometrics (e.g., fingerprint and facial data vulnerabilities), and biohacking (e.g., implantable devices).[1][4][5] Early traction came swiftly: in February 2022, Wallife raised $4.8M in seed funding from over 40 prominent investors, including Technogym's Nerio Alessandri and Proximity Capital's Antonio Assereto, ranking it sixth in Europe for insurtech seed value per Crunchbase; this fueled product development like Biometrics ID and a planned second round.[4][5]
Wallife stands out in the insurtech space through these key strengths:
Wallife rides the wave of exponential tech-driven risks, where AI, biometrics, genetic editing, and biohacking amplify vulnerabilities to personal identity and biology amid rising cyber threats and data breaches.[1][3][5] Timing is ideal post-2020, as global digitization and scientific breakthroughs (e.g., CRISPR, implantable tech) outpace insurance adaptation, creating a $21.85M-validated market gap in Europe’s insurtech boom.[1][4] Favorable forces include regulatory pushes for digital identity protection (e.g., GDPR expansions) and investor appetite for frontier insurtech, positioning Wallife to influence ecosystem standards by patenting protections and partnering on novel products like cryopreservation.[1][3][5] It shapes the landscape by humanizing tech progress, preventing "existential" risks to biological/digital heritage, and inspiring competitors in biometrics-adjacent security.[2][7]
Wallife's trajectory points to scaled product launches in genetics and biohacking insurance, leveraging its seed momentum and tech patents to capture Europe’s underserved "future risks" market.[5][6] Trends like AI-enhanced biometrics, longevity tech, and quantum threats will propel growth, potentially evolving Wallife into a global leader via Series A expansion and U.S./UK entry. Its influence may grow by setting insurtech precedents for sci-tech convergence, turning "unknown risks" into a protectable asset class—echoing its founding mission to safeguard humanity's advancing boundaries.[2][3]
Wallife has raised $12.0M in total across 1 funding round.
Wallife's investors include United Ventures.
Wallife has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $12.0M Series A | United Ventures |